Search

News ... prognostische Marker helfen, den Verlauf der Erkrankung wesentlich besser beurteilen zu können. Die Studie entstand in der Arbeitsgruppe rund um den Wiener Pathologen Lukas Kenner, stellvertretender Leiter des Klinischen Institutes für Pathologie der MedUni Wien und zugleich Leiter der Abteilung für... https://www.meduniwien.ac.at/web/ueber-uns/news/detail/jan-pencik-erhaelt-novartis-preis-der-deutschen-gesellschaft-fuer-pathologie/

Poster prizes for young scientists from MedUni Vienna's Department of Pathology ... the Medical University of Vienna and specifically to its Division of Experimental Pathology.Huang-Chang Liang from Olaf Merkel's group won the prize for his paper: "The AP-1 -BATF and -BATF3 module is essential for growth and survival of anaplastic large cell lymphoma" Jan Pencik from Lukas Kenner... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2017/news-september-2017/poster-prizes-for-young-scientists-from-meduni-viennas-department-of-pathology/

Poster prizes for young scientists from MedUni Vienna's Department of Pathology ... the Medical University of Vienna and specifically to its Division of Experimental Pathology.Huang-Chang Liang from Olaf Merkel's group won the prize for his paper: "The AP-1 -BATF and -BATF3 module is essential for growth and survival of anaplastic large cell lymphoma" Jan Pencik from Lukas Kenner... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2017/news-september-2017/poster-prizes-for-young-scientists-from-meduni-viennas-department-of-pathology/people-of-the-meduni-vienna/

Gastric cancer: Biomarkers identified to predict the risk of relapse .... In their analyses of tumour samples from 182 patients who had undergone surgery for gastric cancer at MedUni Vienna/University Hospital Vienna, the research team led by Elisabeth Gruber (Department of General Surgery) and Lukas Kenner (Department of Pathology) focused on AF1Q. This is a gene that was... https://www.meduniwien.ac.at/web/en/about-us/news/2024/news-in-july-2024/gastric-cancer-biomarkers-identified-to-predict-the-risk-of-relapse/medicine-science/

Gastric cancer: Biomarkers identified to predict the risk of relapse .... In their analyses of tumour samples from 182 patients who had undergone surgery for gastric cancer at MedUni Vienna/University Hospital Vienna, the research team led by Elisabeth Gruber (Department of General Surgery) and Lukas Kenner (Department of Pathology) focused on AF1Q. This is a gene that was... https://www.meduniwien.ac.at/web/en/about-us/news/2024/news-in-july-2024/gastric-cancer-biomarkers-identified-to-predict-the-risk-of-relapse/

Neue Methode zur Lokalisierung von Mikroplastik in Körpergewebe ... photothermale Infrarotspektroskopie) und wurde ursprünglich entwickelt, um chemische Strukturen in komplexen Materialien mit hoher Ortsauflösung sichtbar zu machen. Im Rahmen der aktuelle publizierten Forschungsarbeiten hat das wissenschaftliche Team um Lukas Kenner vom Klinischen Institut für Pathologie der... https://www.meduniwien.ac.at/web/ueber-uns/news/2025/news-im-november-2025/neue-methode-zur-lokalisierung-von-mikroplastik-in-koerpergewebe/

Neue Methode zur Lokalisierung von Mikroplastik in Körpergewebe ... photothermale Infrarotspektroskopie) und wurde ursprünglich entwickelt, um chemische Strukturen in komplexen Materialien mit hoher Ortsauflösung sichtbar zu machen. Im Rahmen der aktuelle publizierten Forschungsarbeiten hat das wissenschaftliche Team um Lukas Kenner vom Klinischen Institut für Pathologie der... https://www.meduniwien.ac.at/web/ueber-uns/news/2025/news-im-november-2025/neue-methode-zur-lokalisierung-von-mikroplastik-in-koerpergewebe/medizin-wissenschaft/

Prostatakarzinom: Protein µ-Crystallin CRYM hemmt das Tumorwachstum ... Therapieformen dringend notwendig. Ein Forschungsteam um Osman Aksoy, Jan Pencik, Olaf Merkel und Lukas Kenner vom klinischen Institut für Pathologie der MedUni Wien konnte nun in einer genetischen Analyse zahlreicher Gewebeproben zeigen, dass das Protein µ-Crystallin (CRYM) eine wesentliche Rolle beim Wachstum... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2020/news-im-november-2020/prostatakarzinom-protein-u-crystallin-crym-hemmt-das-tumorwachstum/medizin-wissenschaft/

Prostatakarzinom: Protein µ-Crystallin CRYM hemmt das Tumorwachstum ... Therapieformen dringend notwendig. Ein Forschungsteam um Osman Aksoy, Jan Pencik, Olaf Merkel und Lukas Kenner vom klinischen Institut für Pathologie der MedUni Wien konnte nun in einer genetischen Analyse zahlreicher Gewebeproben zeigen, dass das Protein µ-Crystallin (CRYM) eine wesentliche Rolle beim Wachstum... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2020/news-im-november-2020/prostatakarzinom-protein-u-crystallin-crym-hemmt-das-tumorwachstum/

Jan Pencik wins Nature Poster Prize ... visiting researcher at the University of Stuttgart (Germany) before starting his doctoral thesis under Lukas Kenner at the LBI-CR in Vienna in 2010. Since completing his PhD, he has been working as a postdoc in Lukas Kenner's working group at MedUni Vienna's Department of Pathology and at the Center for Biomarker Research in Medicine (CBmed). The study was produced under the supervision of Lukas Kenner and Brigitte Hantusch as part of joint project with the Division of Nuclear Medicine and the Center for Biomarker Research in Medicine (CBmed GmbH, www.cbmed.org). Jan Pencik has already won several national and international prizes for his research. Since completing his PhD course, he has been working as a postdoc in Lukas Kenner's working group. From January 2019 he will move for a new position at the Salk Institute for Biological Studies, La Jolla, California, USA. Share Whatsapp Facebook Linked... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2018/news-october-2018/jan-pencik-wins-nature-poster-prize/

Persons

Webseiten-Inhalte